跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
周 德盈
教授
,
臨床醫學研究所
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學癌症轉譯研究中心
電子郵件
tehying
gmail
com
h-index
10787
引文
49
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1989 …
2025
每年研究成果
概覽
指紋
網路
專案
(6)
研究成果
(228)
類似的個人檔案
(11)
指紋
查看啟用 Teh-Ying Chou 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Lung Adenocarcinoma
100%
Neoplasm
91%
Lung Cancer
88%
Epidermal Growth Factor Receptor
61%
Non Small Cell Lung Cancer
49%
Metastatic Carcinoma
41%
Recurrent Disease
40%
Prognostic Factor
34%
Esophageal Squamous Cell Carcinoma
34%
Surgery
26%
Overall Survival
26%
Immunohistochemistry
22%
Malignant Neoplasm
21%
Adenocarcinoma
20%
Programmed Death 1 Ligand 1
18%
Diagnosis
17%
Pneumonectomy
15%
Micropapillary
14%
Pathologist
14%
Distant Metastasis
13%
Tumor Cell
12%
Pathology of Lung Cancer
12%
Primary Tumor
11%
Carcinoma
11%
Biological Marker
10%
Non-Small Cell Lung Cancer
10%
Cancer Cell
10%
Disease
10%
Multivariate Analysis
9%
Lymph Node
9%
Esophagectomy
9%
Next Generation Sequencing
9%
Computer Assisted Tomography
9%
Biopsy
9%
Cancer
9%
Tumor Recurrence
8%
Disease Free Survival
8%
Lymph Node Metastasis
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Thymoma
8%
Human Cytomegalovirus
8%
Survival Rate
8%
Squamous Cell Lung Carcinoma
8%
Immunotherapy
7%
Gene Expression
7%
COVID-19
7%
Hazard Ratio
7%
Morphology
7%
Lung
7%
Cancer Staging
7%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Adenocarcinoma
74%
Neoplasm
68%
Epidermal Growth Factor Receptor
57%
Lung Cancer
49%
Non Small Cell Lung Cancer
41%
Recurrent Disease
23%
Malignant Neoplasm
22%
Esophageal Squamous Cell Carcinoma
19%
Overall Survival
18%
Disease
17%
Colorectal Carcinoma
15%
Adenocarcinoma
12%
Tumor Growth
12%
Human Cytomegalovirus
11%
SARS Coronavirus
10%
Progression Free Survival
9%
Erlotinib
8%
Gefitinib
8%
Mitochondrial DNA
8%
Decoy Receptor 3
8%
Protein Tyrosine Kinase Inhibitor
8%
Metastasis
8%
Chemotherapy
7%
Coronavirinae
7%
Programmed Death 1 Ligand 1
7%
Biological Marker
6%
Primary Tumor
6%
Distant Metastasis
6%
Cytokine
6%
Survival Rate
6%
Vinorelbine
5%
Head and Neck Cancer
5%
Protein P53
5%
Epidermal Growth Factor Receptor Kinase Inhibitor
5%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
41%
Cancer Cell
20%
Cell Migration
13%
Overall Survival
11%
Gene Expression
9%
Tumor Progression
9%
N-Acetylglucosamine
8%
Next Generation Sequencing
8%
Wild Type
7%
P53
7%
Cell Invasion
7%
Gene Expression Profiling
7%
Protein Phosphorylation
7%
Genetics
7%
Mesenchymal-Epithelial Transition
6%
Drug Resistance
6%
Genomics
5%
Transferase
5%
Eicosanoid Receptor
5%
Protein Glycosylation
5%
Immune Checkpoints
5%
Glycosylation
5%
Tyrosine Kinase Inhibitor
5%
Monospecific Antibody
5%
Cell Death
5%
Gene Mutation
5%
